Siobhan Schabrunprofile image
Dr

Siobhan Schabrun


Current Appointments

Senior Research Scientist and Group Leader, NeuRA
Director, Centre for Pain IMPACT, NeuRA R.D Wright Biomedical Fellow, NHMRC
email hidden; JavaScript is required

Dr Siobhan Schabrun trained as a physiotherapist before completing a PhD in neuroscience at The University of Adelaide in 2009. Supported by a NHMRC Early Career Fellowship, she undertook post-doctoral training in pain neuroscience at The University of Queensland. In 2014, she received a Fulbright scholarship to further her interest in the neuroplasticity of pain in the USA and was awarded a QLD Young Tall Poppy Science Award. In 2018 she moved to NeuRA where she leads a program of research that seeks to understand why some people recover after an episode of musculoskeletal pain while others develop long-lasting, disabling pain. She is the 2020 Ulf Lindblom Award Recipient for an outstanding young clinical investigator in the field of pain.

Research interests include the discovery of biomarkers that can predict who will develop chronic pain – even before pain begins, investigation of the neurobiological mechanisms that underpin the transition from acute to chronic pain and the development and testing of non-invasive brain stimulation treatments for chronic pain. She is also passionate about improving the translation of research evidence into clinical practice. Follow Siobhan’s work on Google Scholar.

Siobhan is deputy lead of the low back pain working group of the SPHERE musculoskeletal clinical academic group, a nominated member of the Global Young Academy and is one of the inaugural Superstars of STEM.


Publications

2024, 17 Sep

Integrated care for adults with chronic musculoskeletal disorders: a scoping review protocol

View full journal-article on https://doi.org/10.11124/JBIES-23-00534

2024 Aug

Can non‐invasive brain stimulation modulate peak alpha frequency in the human brain? A systematic review and meta‐analysis

View full journal-article on https://doi.org/10.1111/ejn.16424

2024, 14 Jun

Peak alpha frequency is not significantly altered by five days of experimental pain and repetitive transcranial stimulation of the left dorsolateral prefrontal cortex

View full preprint on https://doi.org/10.1101/2024.06.14.599003

2024, 17 Apr

Can we Find Evidence for the Null in a Bayesian t-Test? Not Unless we Reconsider Bayes Factor Thresholds

View full preprint on https://doi.org/10.31234/osf.io/kytj7

2023, 14 Dec

Phosphene and Motor Transcranial Magnetic Stimulation Thresholds Are Correlated: A Meta-Analytic Investigation

View full preprint on https://doi.org/10.1101/2023.12.12.571304

2023, 17 Nov

Effects of nicotine compared to placebo gum on sensitivity to pain and mediating effects of peak alpha frequency

View full preprint on https://doi.org/10.7554/eLife.91933.1

2023, 17 Nov

Effects of nicotine compared to placebo gum on sensitivity to pain and mediating effects of peak alpha frequency

View full preprint on https://doi.org/10.7554/eLife.91933

2023, 16 Nov

Can non-invasive brain stimulation modulate peak alpha frequency in the human brain? A systematic review and meta-analysis

View full preprint on https://doi.org/10.1101/2023.11.13.566909

2023, 14 Aug

Effects of nicotine compared to placebo gum on sensitivity to pain and mediating effects of peak alpha frequency

View full preprint on https://doi.org/10.1101/2023.08.11.552723

2023, 29 Jun

Systemic pro- and anti-inflammatory profiles in acute non-specific low back pain: An exploratory longitudinal study of the relationship to six-month outcome

View full journal-article on https://doi.org/10.1371/journal.pone.0287192